With respect to conferences and continuing medical education, there's no need for this to be "subsidized" by drug companies, such conferences are already expensive to attend, despite such "subsidies" in any case.

Perhaps the conferences would end up being in less glamorous locations, but that would have little impact on their educational benefit.